|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 9/28 | (2006.01) | ||
| A61K 9/50 | (2006.01) | ||
| A61K 31/485 | (2006.01) | ||
| A61K 47/10 | (2006.01) | ||
| A61K 47/36 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61P 25/04 | (2006.01) |
| (11) | Number of the document | 2605757 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11758519.0 |
| Date of filing the European patent application | 2011-08-18 | |
| (97) | Date of publication of the European application | 2013-06-26 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-01 |
| (46) | Date of publication of the claims translation | 2015-10-26 |
| (86) | Number | PCT/FR2011/051929 |
| Date | 2011-08-18 |
| (87) | Number | WO 2012/022919 |
| Date | 2012-02-23 |
| (30) | Number | Date | Country code |
| 1056689 | 2010-08-20 | FR |
| (72) |
LEBON, Christophe, FR
SUPLIE, Pascal, FR
PAUL, David Olivier, FR
|
| (73) |
Debregeas Et Associes Pharma,
79 rue de Miromesnil, 75008 Paris,
FR
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Kompozicijos nalbufino pagrindu ir jų panaudojimas |
| NALBUPHINE-BASED FORMULATIONS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2019-08-13 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-08-18 |